{
    "2021-05-27": [
        [
            {
                "time": "2021-04-15",
                "original_text": "Best Dividend Stocks to Buy According to Cathie Wood",
                "features": {
                    "keywords": [
                        "dividend",
                        "stocks",
                        "Cathie Wood"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "investing"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-06-18",
                "original_text": "Novartis (NVS) & Molecular Partners Initiate Study for COVID-19",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Molecular Partners",
                        "COVID-19",
                        "study"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-07-20",
                "original_text": "Novartis and Molecular Partners Begin EMPATHY Clinical Trial",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Molecular Partners",
                        "EMPATHY",
                        "clinical trial"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-08-10",
                "original_text": "Novartis, Molecular Partners Initiate Global Trial For COVID-19 Treatment",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Molecular Partners",
                        "global trial",
                        "COVID-19",
                        "treatment"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-11-03",
                "original_text": "Novartis and Molecular Partners announce start of EMPATHY clinical trial for ensovibep for the treatment of COVID-19",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Molecular Partners",
                        "EMPATHY",
                        "clinical trial",
                        "ensovibep",
                        "COVID-19",
                        "treatment"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}